| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |